These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 233952)

  • 1. Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.
    Larsson M; Vorrsjö E; Talmud P; Lookene A; Olivecrona G
    J Biol Chem; 2013 Nov; 288(47):33997-34008. PubMed ID: 24121499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-apolipoprotein changes in renal transplant recipients.
    Cassader M; Ruiu G; Gambino R; Alemanno N; Triolo G; Veglia F; Pagano G
    Lipids; 2002 Oct; 37(10):967-74. PubMed ID: 12530556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].
    Hörl WH; Hörl M; Heidland A
    Klin Wochenschr; 1982 Apr; 60(7):327-36. PubMed ID: 6122754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine and metabolic abnormalities following kidney transplantation.
    Hörl WH; Riegel W; Wanner C; Haag-Weber M; Schollmeyer P; Wieland H; Wilms H
    Klin Wochenschr; 1989 Sep; 67(17):907-18. PubMed ID: 2681969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of normal plasma lipases by serum from chronic renal failure patients.
    Crawford GA; Savdie E; Stewart JH; Mahony JF
    Trans Am Soc Artif Intern Organs; 1979; 25():426-30. PubMed ID: 524618
    [No Abstract]   [Full Text] [Related]  

  • 6. Positional specificity of triglyceride lipases in post-heparin plasma.
    Assmann G; Krauss RM; Fredrickson DS; Levy RI
    J Biol Chem; 1973 Oct; 248(20):7184-90. PubMed ID: 4743519
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.
    Huttunen JK; Pasternack A; Vänttinen T; Ehnholm C; Nikkilä EA
    Acta Med Scand; 1978; 204(3):211-8. PubMed ID: 211802
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective deficiency of hepatic triglyceride lipase in uremic patients.
    Mordasini R; Frey F; Flury W; Klose G; Greten H
    N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of furosemide on the lipid abnormalities in chronic renal failure.
    Pasternack A; Leino T; Solakivi-Jaakkola T; Huttunen JK; Ehnholm C
    Acta Med Scand; 1983; 214(2):153-7. PubMed ID: 6624545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-released plasma lipases in chronic renal failure and after renal transplantation.
    Crawford GA; Savdie E; Stewart JH
    Clin Sci (Lond); 1979 Aug; 57(2):155-65. PubMed ID: 233952
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid abnormalities in uremia, dialysis, and transplantation.
    Chan MK; Varghese Z; Moorhead JF
    Kidney Int; 1981 May; 19(5):625-37. PubMed ID: 7026870
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of lipoproteinlipase and hepatic triglyceride lipase in the metabolism of triglyceride-rich lipoproteins (author's transl)].
    Bolzano K
    Wien Klin Wochenschr Suppl; 1979; 101():1-20. PubMed ID: 382642
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.